Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000128275 | SCV000171867 | benign | not specified | 2013-06-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000535634 | SCV000633800 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312616 | SCV000846749 | likely benign | Inborn genetic diseases | 2016-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001808390 | SCV002056718 | benign | Developmental and epileptic encephalopathy, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003884355 | SCV004700828 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SPTAN1: BP4, BP7, BS1 |
Prevention |
RCV003905221 | SCV004733762 | benign | SPTAN1-related condition | 2019-05-22 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |